Vaxtrials, Part Of Emmes Group

Vaxtrials, Part Of Emmes Group company information, Employees & Contact Information

Welcome to VaxTRIALS, part of Emmes Group, your trusted full-service global partner in Clinical Research Organization (CRO) services specialized in vaccines. With over 35 years in business and operations in more than 60 countries, alongside our dedicated focus on managing and monitoring trials, we're committed to delivering innovative solutions that exceed our client's expectations. What sets us apart is our team's unparalleled expertise, honed through years of experience and a deep understanding of the local regulatory landscape worldwide. Combined with our extensive knowledge of the local context and a solid network of experienced investigators, we are uniquely positioned to ensure rapid enrollment and adherence to the highest quality standards. At VaxTRIALS, our driving force is the opportunity to make a meaningful contribution to public health by accelerating the path to the eradication of preventable diseases. With an unwavering dedication to excellence and a close partnership with our clients, we aim to be at the forefront of the fight against global health challenges. Join us in our mission to make a difference in healthcare and research. Together, we're shaping a healthier future. #ClinicalResearch #PublicHealth #VaccineTrials #HealthcareInnovation

Company Details

Employees
67
Address
Panamá, Panamá, Pa
Industry
Research Services
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Keywords
Panamá.
HQ
Panamá, Panamá
Looking for a particular Vaxtrials, Part Of Emmes Group employee's phone or email?

Vaxtrials, Part Of Emmes Group Questions

News

Emmes Acquires VaxTRIALS - PR Newswire

Emmes Acquires VaxTRIALS PR Newswire

Emmes buys VaxTrials to tap Latin American market - BioXconomy

Emmes buys VaxTrials to tap Latin American market BioXconomy

Rockville company gains Latin American base with acquisition of VaxTRIALS - Maryland Daily Record

Rockville company gains Latin American base with acquisition of VaxTRIALS Maryland Daily Record

Rockville clinical research organization Emmes continues buying spree with deal for Latin American firm - The Business Journals

Rockville clinical research organization Emmes continues buying spree with deal for Latin American firm The Business Journals

Biostatisticians draft blueprints for COVID-19 vax trials - Fred Hutchinson Cancer Center

Biostatisticians draft blueprints for COVID-19 vax trials Fred Hutchinson Cancer Center

ILiAD Biotechnologies Announces Planned Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, to Conduct Upcoming Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine - Business Wire

ILiAD Biotechnologies Announces Planned Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, to Conduct Upcoming Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine Business Wire

Gates Foundation commits up to $90M for Inventprise pneumococcal vax trials - MedCity News

Gates Foundation commits up to $90M for Inventprise pneumococcal vax trials MedCity News

Emmes Group to conduct Phase III studies of ILiAD Biotechnologies pertussis vaccine candidate, BPZE1 - ET HealthWorld

Emmes Group to conduct Phase III studies of ILiAD Biotechnologies pertussis vaccine candidate, BPZE1 ET HealthWorld

Over 900 villages declared ASF-free; vax trials ongoing - Philippine News Agency

Over 900 villages declared ASF-free; vax trials ongoing Philippine News Agency

Top Vaxtrials, Part Of Emmes Group Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant